Bioequivalence Study
Showing 1 - 25 of 2,708
Bioequivalence Study Trial in Chennai (Pomalidomide 4 MG Oral Capsule)
Not yet recruiting
- Bioequivalence Study
- Pomalidomide 4 MG Oral Capsule
-
Chennai, Tamil Nadu, IndiaAzidus Laboratories
Sep 22, 2023
Bioequivalence Trial in Haikou (Amphotericin B liposome for injection, AmBisome)
Active, not recruiting
- Bioequivalence
- Amphotericin B liposome for injection
- AmBisome
-
Haikou, Hainan, ChinaHaikou people's Hospital
Jun 12, 2023
Healthy Trial (Test (T) Bilastine, Reference (R) Bilastine)
Not yet recruiting
- Healthy
- Test (T) Bilastine
- Reference (R) Bilastine
- (no location specified)
Oct 19, 2023
Myeloma Multiple Trial in Chia (Dasatinib 100 MG)
Not yet recruiting
- Myeloma Multiple
- Dasatinib 100 MG
-
Chia, Cundinamarca, ColombiaCAIMED
Jul 12, 2023
Bioequivalence Study Trial in Beijing (Calcium Hydroxybenzene Sulphonate Dispersible Tablets 0.25g, Calcium Hydroxybenzene
Recruiting
- Bioequivalence Study
- Calcium Hydroxybenzene Sulphonate Dispersible Tablets 0.25g
- Calcium Hydroxybenzene Sulfonate Tablets(Doxium®) 250mg
-
Beijing, Beijing, ChinaNational Institue for Drug Clinical Trials
Mar 21, 2023
Bioequivalence Trial in Larissa (Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals,
Recruiting
- Bioequivalence
- Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
- ADVAIR DISKUS® 500/50
-
Larissa, Thessaly, GreeceBECRO Clinical Facility
Aug 29, 2023
Healthy Trial in Cairo (Bravamax 200 mg (Modafinil), Vigil 200 mg (Modafinil))
Completed
- Healthy
- Bravamax 200 mg (Modafinil)
- Vigil 200 mg (Modafinil)
-
Cairo, EgyptGenuine Research Center GRC
May 3, 2023
Bioequivalence Trial in Larissa (Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals,
Recruiting
- Bioequivalence
- Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
- ADVAIR DISKUS® 250/50
-
Larissa, Thessaly, GreeceBECRO Clinical Facility
Aug 1, 2023
Tumors Trial in Bengbu (The test olaparib tablet (T), The reference olaparib tablet (R))
Completed
- Neoplasms
- The test olaparib tablet (T)
- The reference olaparib tablet (R)
-
Bengbu, Anhui, ChinaThe First Affiliated Hospital of Bengbu Medical College
May 15, 2023
Bioequivalence, Healthy Subjects Trial in Amman (Efez 50 mg eplerenone film-coated tablets, INSPRA® 50 mg eplerenone film-coated
Completed
- Bioequivalence
- Healthy Subjects
- Efez 50 mg eplerenone film-coated tablets
- INSPRA® 50 mg eplerenone film-coated tablets
-
Amman, JordanACDIMA Center for Bioequivalence and Pharmaceutical Studies
Dec 15, 2022
Hyperlipidemias Trial in Qingdao (ezetimibe tablet, ezetimibe tablet(Ezetrol ®))
Completed
- Hyperlipidemias
- ezetimibe tablet
- ezetimibe tablet(Ezetrol ®)
-
Qingdao, Shandong, ChinaClinical Research Center
Dec 27, 2022
Bioequivalence, Schizophrenia Trial in Qingdao (Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and
Recruiting
- Bioequivalence
- Schizophrenia
- Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and supplied by Zezheng (Shanghai) Biotechnology Co., Ltd.
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University Phase I Clinical R
Sep 27, 2023
Healthy Trial in Cairo (Apipe (Aripiprazole10 mg), Abilify (Aripiprazole10 mg))
Completed
- Healthy
- Apipe (Aripiprazole10 mg)
- Abilify (Aripiprazole10 mg)
-
Cairo, EgyptGenuine Research Center GRC
Mar 27, 2023
Pharmacokinetics, Bioequivalence Trial in Dallas (Sumatriptan (via Intraject System))
Completed
- Pharmacokinetics
- Bioequivalence
- Sumatriptan (via Intraject System)
-
Dallas, TexasCovance, Inc
Nov 8, 2022
Healthy Adult Subjects Trial in San Antonio (TTYP01, Radicava, Radicava ORS)
Recruiting
- Healthy Adult Subjects
- TTYP01
- +2 more
-
San Antonio, TexasICON Early Phase Services
Oct 24, 2023
Healthy Volunteers, Bioequivalence Study Trial in Karachi (Neurogabin (Gabapentin) 400 mg capsule, Parketin (Gabapentin) 400 mg
Completed
- Healthy Volunteers
- Bioequivalence Study
- Neurogabin (Gabapentin) 400 mg capsule
- Parketin (Gabapentin) 400 mg capsule
-
Karachi, Sindh, PakistanCenter for Bioequivalence Studies and clinical research (CBSCR),
Jul 1, 2022
Healthy, Pharmacokintetics Trial in Karachi (Levofloxacin 500mg)
Completed
- Healthy
- Pharmacokintetics
- Levofloxacin 500mg
-
Karachi, Sindh, PakistanCenter for Bioequivalence Studies and clinical research (CBSCR),
Sep 5, 2022
Bioequivalence Trial (Fluticasone propionate 1000 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals, ADVAIR DISKUS
Not yet recruiting
- Bioequivalence
- Fluticasone propionate 1000 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
- ADVAIR DISKUS 100/50
- (no location specified)
Jan 20, 2023
Therapeutic Equivalency Trial in Qingdao (Tested Irbesartan Tablet, Reference Irbesartan Tablet)
Completed
- Therapeutic Equivalency
- Tested Irbesartan Tablet
- Reference Irbesartan Tablet
-
Qingdao, Shandong, ChinaAffiliated Hospital of Qingdao University Phase I Clinical Resea
Mar 24, 2023
Healthy Subject Trial in Seoul (Neomazine Tab. 100mg, Myungin Chlorpromazine HCl Tab. 100mg)
Completed
- Healthy Subject
- Neomazine Tab. 100mg
- Myungin Chlorpromazine HCl Tab. 100mg
-
Seoul, Korea, Republic ofWhan In Pharm.
Nov 23, 2023
Healthy Trial in Qingdao (test apixaban tablets, reference apixaban tablets)
Completed
- Healthy
- test apixaban tablets
- reference apixaban tablets
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University Phase I Clinical R
May 1, 2023